Shared and unique gene expression in systemic lupus erythematosus depending on disease activity

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 493-500

  Sandrin Garcia, Paula ^a   Junta, Cristina Moraes ^a   Fachin, Ana L ^a   Mello, Stephano S ^a   Baião, Ana Maria T ^a   Rassi, Diane M ^b   Ferreira, Márcia C T ^a   Trevisan, Glauce L ^a   Sakamoto Hojo, Elza T ^a,b   Louzada Júnior, Paulo ^b   Passos, Geraldo A S ^a,b   Donadi, Eduardo A ^b  

^a Molecular Immunogenetics Group (Department of Genetics)   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Active disease; Gene expression; Lupus erythematosus; Microarrays

Indexed keywords

COMPLEMENTARY DNA; DNA; FLUOROCHROME; RNA;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ACTIVITY; DNA MICROARRAY; DNA PROBE; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REPRESSION; HUMAN; IMMUNOREGULATION; MICROARRAY ANALYSIS; PERIPHERAL LYMPHOCYTE; REVERSE TRANSCRIPTION; RNA ISOLATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 69949151373     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04636.x     Document Type: Conference Paper

References (25)

1. Liu, C.C., S. Manzi & J.M. Ahearn. 2005. Biomark-ers for systemic lupus erythematosus: a review and perspective. Curr. Opin. Rheumatol. 17: 543-549. (Pubitemid 41527813)
2. Fritzler, M.J. 2008. Challenges to the use of autoan-tibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun. Rev. 7: 616-620.
3. Magalhães, M.B. et al. 2007. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations. Scand. J. Rheumatol. 36: 442-447.
4. Lleo, A. et al. 2008. The consequences of apoptosis in autoimmunity. J. Autoimmun. 31: 257-262.
5. Wakeland, E.K. et al. 2001. Delianeating the genetic basis of systemic lupus erythematosus. Immunity 15: 397-408.
6. Jordan, M.A. & A.G. Baxter. 2008. The genetics of immunoregulatory T cells. J. Autoimmun. 31: 237-244.
7. Freitas, M.V. et al. 2004. Is HLA class II susceptibility to primary antiphospholipid syndrome different from susceptibility to secondary antiphospholipid syndrome? Lupus 13: 125-131.
8. Silva, L.M. & E.A. Donadi. 1996. Is immunogenetic susceptibility to active systemic lupus erythematosus (SLE) different from non-active SLE? Ann. Rheum. Dis. 55: 544-547.
9. Castro, J. et al. 2008. The complex immunogenetic basis of systemic lupus erythematosus. Autoimmun. Rev. 7: 345-351.
10. Brown, P.O. & D. Botstein. 1999. Exploring the new world of the genome with DNA microarrays. Nat. Genet. 21: 33-37.
11. Rus, V. et al. 2002. Expression of cytokine and chemokine related genes in peripheral blood mononuclear cells from lupus patients by cDNA arrays. Clin. Immunol. 102: 283-290.
12. Pereira E. et al. 2004. Immunosuppressive therapy modulates T lymphocyte gene expression in patients with systemic lupus erythematosus. Immunol. 113: 99-105.
13. Bennet, L. et al. 2003. Interferon and granulopoiesis signatures in systemic lupus eruthematosus blood. J. Exp. Med. 6: 711-713.
14. Blank, M. & M.E. Gershwin. 2008. Autoimmunity: from the mosaic to the kaleidoscope. J. Autoimmun. 30: 1-4.
15. Tan, E.M. et al. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
16. Gladman, D.D., D. Ibanez & M.B. Urowitz. 2002. Systemic lupus erythematosus activity index 2000. J. Rheumatol. 29: 288-291.
17. Hedge, P. et al. 2000. A concise guide to cDNA mi-croarray analysis. BioTechniques 29: 548-562.
18. Griffiths, E.K. et al. 2001. Positive regulation of T cell activation and integrin adhesion by the adapter Fyb/Slap. Science 293: 2260-2263.
19. Yu, C.C. et al. 2001. Lupus-like kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn. Curr. Biol. 11: 34-38.
20. Li, N. et al. 2004. Gain-of-function polymorphism in mouse and human Ltk: implications for the patho-genesis of systemic lupus erythematosus. Hum. Mol. Genet. 13: 171-179.
21. Kumanogoh, A. et al. 2002. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature 419: 629-633.
22. Lavin, M.F. 1999. ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia. Int. J. Radiat. Biol. 75: 1201-1214.
23. DeGiorgio, L.A. et al. 2001. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7: 1189-1193.
24. Castelletti, F. et al. 2008. Mutations in FN1 cause glomerulopathy with fibronectin deposits. Proc. Natl. Acad. Sci. USA 105: 2538-2543.
25. Doria, A. & P. Sarzi-Puttini. 2008. Infections, rheumatism and autoimmunity: the conflicting relationship between humans and their environment. Autoimmun. Rev. 8: 1-4.